Article - 31/07/2010 Christian Riedel – an outstanding bifidobacteria researcher The 37-year-old microbiologist Christian Riedel was recently awarded the Science Prize of the city of Ulm for his basic research on bifidobacteria. Riedel who is the head of a group of 12 junior researchers at the University of Ulm has shown that bifidobacteria exert an inhibitory effect on chronic bowel inflammation. The researcher hopes to have identified the underlying molecular mechanisms within the next 12 months.https://www.gesundheitsindustrie-bw.de/en/article/news/christian-riedel-an-outstanding-bifidobacteria-researcher
Article - 28/06/2010 ATG:biosynthetics GmbH – Modular molecular systems of the future ATGbiosynthetics GmbH based in Merzhausen close to Freiburg produces biological systems that can combine gene constituents following a construction kit principle. The company provides the pharmaceutical industry and basic researchers with products that have specifically chosen properties.https://www.gesundheitsindustrie-bw.de/en/article/news/atg-biosynthetics-gmbh-modular-molecular-systems-of-the-future
Article - 11/06/2010 Recycling of bacterial cell wall constituents Bacterial cells are focused on growth and proliferation. These processes are initiated by cellular enzymes that break up the cell wall material murein introduce new material and degrade material that is no longer needed. And all this in large amounts about 50 per cent of murein are degraded and newly formed turnover per cell generation. Dr. Christoph Mayer and his team from the University of Constance have shown that the cells carry out effective…https://www.gesundheitsindustrie-bw.de/en/article/news/recycling-of-bacterial-cell-wall-constituents
Press release - 07/06/2010 Addition of renowned experts to Medical Advisory Board and achievement of international quality standards generate added optimism With a € 1.5 Mio Second Closing, Curetis has now increased its Series A financing round to € 20 Mio. This additional financing will enable Curetis to complete the development of its innovative diagnostic products through to market entry. Quality Certification for its diagnostic product development represents an additional milestone in Curetis' commercial strategy. At the same time, Curetis has added internationally recognized expertise in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/addition-of-renowned-experts-to-medical-advisory-board-and-achievement-of-international-quality-stan
Article - 19/04/2010 Trying to get a virus to reveal its tricks The Thogoto virus is an exotic virus that presents virtually no danger to humans. A group of virologists led by Prof. Dr. Georg Kochs at the Freiburg University Medical Centre are using the virus as model system for its particular suitability in certain experiments. The group is investigating how the virus evades the antiviral defence of the infected host.https://www.gesundheitsindustrie-bw.de/en/article/news/trying-to-get-a-virus-to-reveal-its-tricks
Article - 29/03/2010 A ray of light for fungi Breaking through the protective darkness of the soil can be very uncomfortable for fungi because it requires them to adapt quickly to UV radiation or moisture fluctuations. But how do they know that they are on the soil surface? An important parameter is light. Researchers led by Prof. Dr. Reinhard Fischer at the Karlsruhe Institute of Technology (KIT) are investigating how the mould Aspergillus nidulans perceives light and how this governs its…https://www.gesundheitsindustrie-bw.de/en/article/news/a-ray-of-light-for-fungi
Article - 15/03/2010 Borna disease virus and cell death in the brain A research group led by Prof. Dr. Bernd Heimrich at the University of Freiburg is investigating how the Borna disease virus can alter characteristic neuronal circuits and destroy the hippocampal nerve cells. The scientists have developed an extremely practical petri dish test system. Their results show which cell types sustain the most damage following infection and also give indications as to how apoptosis cell death can be prevented.https://www.gesundheitsindustrie-bw.de/en/article/news/borna-disease-virus-and-cell-death-in-the-brain
Article - 15/03/2010 Andreas Diefenbach: A molecular approach to disease mechanisms Prof. Dr. Andreas Diefenbach began his academic career as a philosophy student. Nowadays, the immunologist at the Freiburg University Medical Centre investigates how cells of the innate immune system fight off cancer and infections. He believes that, in contrast to all other subjects, immunology is an area that very much focuses on concepts. Diefenbach’s research frequently gives rise to situations needing new paradigms.https://www.gesundheitsindustrie-bw.de/en/article/news/andreas-diefenbach-a-molecular-approach-to-disease-mechanisms
Article - 15/03/2010 Cystic fibrosis therapy is making good progress Thirty years ago cystic fibrosis CF formerly also known as mucoviscidosis was considered to be a disease that only affected children. Hardly any children with this hereditary metabolic disease ever reached early adulthood. Since then both the therapy and the life expectancy of CF patients have improved considerably. Dr. Gerd Döring from Tübingen is investigating the occurrence of respiratory tract defects that are common in CF patients.https://www.gesundheitsindustrie-bw.de/en/article/news/cystic-fibrosis-therapy-is-making-good-progress
Article - 13/03/2010 Assembling life from building blocks? As part of its “Bioethics Forum”, the German Ethics Council recently held a meeting in Berlin to inform the public about the fundamentals of synthetic biology and potential ethical problems and consequences in terms of our ideas about life and mankind in general arising from the progress made in this new field of research. https://www.gesundheitsindustrie-bw.de/en/article/news/assembling-life-from-building-blocks
Article - 22/02/2010 Treasure trove of data from Ulm helps in the understanding of community-acquired pneumonia CAP community-acquired pneumonia is a common type of pneumonia that mainly affects young and old people. In Germany around 800000 people contract CAP every year and almost one third has to be admitted to hospital exceeding the number of admissions due to cardiac infarction or stroke. The CAPNETZ competence network which up until recently was funded by the German government is gradually shedding light on a hitherto little known disease.https://www.gesundheitsindustrie-bw.de/en/article/news/treasure-trove-of-data-from-ulm-helps-in-the-understanding-of-community-acquired-pneumonia
Article - 11/02/2010 New interfaculty institute combines excellent basic research with clinical application Infection research is one of the major scientific beacons of the University of Tübingen, where the close thematic collaboration between scientists and doctors is the key to success. The close collaboration between scientists and doctors at the university also played a key role in the setting up of two collaborative research centres (SFB). With the recent establishment of the Interfaculty Institute for Microbiology and Infection Medicine (IMIT),…https://www.gesundheitsindustrie-bw.de/en/article/news/new-interfaculty-institute-combines-excellent-basic-research-with-clinical-application
Article - 15/12/2009 Arming the immune system against cancer The theory that immune cells are able to attack tumours has long been a theory with only a minority of supporters. However, this theory is currently experiencing a renaissance. In the future, it might even be possible to specifically alter T-lymphocytes in order to improve their ability to identify and destroy certain tumour types. Prof. Dr. Hanspeter Pircher and his team at the Freiburg University Medical Centre are focusing on the development…https://www.gesundheitsindustrie-bw.de/en/article/news/arming-the-immune-system-against-cancer
Article - 01/12/2009 Ralf Takors – a bio-engineer Multidisciplinary talent, people who can combine biological knowledge in an outstanding way with engineering, is in great demand. Ralf Takors, who has been head of the Institute of Bioprocess Engineering (IBVT) at the University of Stuttgart since July 2009, is one such talent. https://www.gesundheitsindustrie-bw.de/en/article/news/ralf-takors-a-bio-engineer
Article - 10/09/2009 Chaperone research using baker’s yeast and bacteria Protein misfolding and aggregation can lead to neurodegenerative diseases such as Alzheimers. Prof. Elke Deuerling at the University of Constance is investigating the molecular helpers the chaperones and the key role that they have in protein folding. Deuerling uses the bakers yeast Saccharomyces cerevisiae and the bacterium Eschericia coli for her studies. Her studies involving E. coli have now shown that ribosome-associated chaperones are…https://www.gesundheitsindustrie-bw.de/en/article/news/chaperone-research-using-baker-s-yeast-and-bacteria
Press release - 09/09/2009 “Road trip” to the Lake Constance American scientists from the J. Craig Venter Institute JCVI have recently visited the Institute of Limnology at the University of Constance at Lake Constance. The visit was part of the Sorcerer II Expedition which is a unique global mission to sample and discover the diversity of microorganisms and their role in global substance flows. https://www.gesundheitsindustrie-bw.de/en/article/press-release/road-trip-to-the-lake-constance
Press release - 04/09/2009 Motivation impetus for researcher on bacteria Dirk Linke 37 has been awarded the Advancement Award of the German Society for Hygiene and Microbiology Deutsche Gesellschaft für Hygiene und Mikrobiologie DGHM. The award includes prize money of 2500 Euro and will be presented on September 20th 2009 during the 61st Annual Meeting of the DGHM in Göttingen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/motivation-impetus-for-researcher-on-bacteria
Article - 17/08/2009 A kiss of death for cells Prof. Dr. Peter Krammer of the German Cancer Research Centre has considerably contributed to clarifying the apoptotic signalling pathways in both normal and malignant cells. In addition he has developed new therapeutic strategies for the treatment of those diseases that are the result of defective apoptosis regulation.https://www.gesundheitsindustrie-bw.de/en/article/news/a-kiss-of-death-for-cells
Press release - 10/08/2009 How do immune cells recognise infectious pathogens? Scientists of the University of Heidelberg and the German Cancer Research Centre have clarified the functional principles of an important receptor for bacterial infections: immune cells recognise bacterial and viral pathogens with a receptor known as toll-like receptor 9 (TLR9), which mediates biochemical reaction chains in order to fend off intruders. This discovery made by the Heidelberg researchers paves the way to develop new anti-infective…https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-do-immune-cells-recognise-infectious-pathogens
Dossier - 30/07/2009 Downstream processing: bottleneck purification process The fermentation processes that are used by biopharmaceutical manufacturers have shown to lead to increasing quantities of therapeutic proteins. However this increase in turn leads to capacity bottlenecks in the subsequent purification process known as downstream processing and is associated with high costs. Downstream processing comprises up to 80 per cent of the entire production costs. Producers are increasingly recognising the present need…https://www.gesundheitsindustrie-bw.de/en/article/dossier/downstream-processing-bottleneck-purification-process
Article - 24/06/2009 The initiation of replication – only once, please DNA replication is a critical event in the cell division process. The genetic material must only be replicated once. So, how does a bacterial cell ensure that only one single replication occurs and that the process is not repeated several times? Microbiologists under the leadership of Prof. Dr. Peter Graumann from the Institute of Biology II in Freiburg, in cooperation with international cooperation partners from Paris, have deciphered a…https://www.gesundheitsindustrie-bw.de/en/article/news/the-initiation-of-replication-only-once-please
Press release - 01/05/2009 They have the super cell In the Year of Science which is being celebrated in the city of Constance in 2009 the company Trenzyme located in the Constance industrial park is a prime example of science and industry working successfully hand in hand on the Nycomed campus.https://www.gesundheitsindustrie-bw.de/en/article/press-release/they-have-the-super-cell
Article - 21/04/2009 Two separate defence systems? Are the innate and the adaptive immune systems really completely independent from each other? Dr. Mathias Lucas from the University of Freiburg investigates receptor proteins that are found in the cells of both systems. It is possible that such systems might not only play a role in infections or cancer, but also in autoimmune diseases such as rheumatoid arthritis. https://www.gesundheitsindustrie-bw.de/en/article/news/two-separate-defence-systems
Article - 07/04/2009 Hendrik Küpper – at the service of plants and humans Prof. Hendrik Küpper had his first experience as a scientist in 1992 when together with his brother and a friend he participated in the German governments Jugend forscht contest. The students came first in biology in the national competition and first in both the Young Europeans Environmental Research Contest and the European Community Contest for Young Scientists. Back then Küpper was already interested in the interaction between heavy metals…https://www.gesundheitsindustrie-bw.de/en/article/news/hendrik-kuepper-at-the-service-of-plants-and-humans
Article - 30/03/2009 More than milk and business Although there is very little difference between the biotechnological methods used in the dairy industry and those used in other industries nevertheless biotechnology operates differently here. Why can certain goals sometimes be reached more effectively without academic research?https://www.gesundheitsindustrie-bw.de/en/article/news/more-than-milk-and-business